{"DataElement":{"publicId":"5243420","version":"1","preferredName":"Medulloblastoma Central Pathology Review Histologic Classification Type","preferredDefinition":"The classifications for the molecularly distinct histological subtypes of medulloblastoma that are defined by unique molecular profiles, clinical behavior and outcomes - based upon the determination by a central pathology reviewer.","longName":"MBPthRvHistClassType","context":"COG","contextVersion":"1","DataElementConcept":{"publicId":"5242470","version":"1","preferredName":"Medulloblastoma Histologic Central Pathology Review Description","preferredDefinition":"A malignant, invasive embryonal neoplasm arising from the cerebellum. It occurs predominantly in children and has the tendency to metastasize via the cerebrospinal fluid pathways. Signs and symptoms include truncal ataxia, disturbed gait, lethargy, headache, and vomiting. There are four histologic variants: anaplastic medulloblastoma, desmoplastic/nodular medulloblastoma, large cell medulloblastoma, and medulloblastoma with extensive nodularity._Pertaining to the combined microscopic physical features of cells and their surrounding extracellular environment in tissues._The process by which specimens are sent to a central lab for confirmatory analysis using standardized methods and result criteria in order to minimize inter-reviewer differences thereby improving the accuracy of pathology data._A written or verbal account, representation, statement, or explanation of something.","longName":"5242467v1.0:5242468v1.0","context":"COG","contextVersion":"1","ObjectClass":{"publicId":"5242467","version":"1","preferredName":"Medulloblastoma","preferredDefinition":"A malignant, invasive embryonal neoplasm arising from the cerebellum. It occurs predominantly in children and has the tendency to metastasize via the cerebrospinal fluid pathways. Signs and symptoms include truncal ataxia, disturbed gait, lethargy, headache, and vomiting. There are four histologic variants: anaplastic medulloblastoma, desmoplastic/nodular medulloblastoma, large cell medulloblastoma, and medulloblastoma with extensive nodularity.","longName":"C3222","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Medulloblastoma","conceptCode":"C3222","definition":"A malignant, invasive embryonal neoplasm arising from the cerebellum or posterior fossa. It occurs predominantly in children and has the tendency to metastasize via the cerebrospinal fluid pathways. Signs and symptoms include truncal ataxia, disturbed gait, lethargy, headache, and vomiting. There are four histologic variants: classic medulloblastoma, large cell/anaplastic medulloblastoma, desmoplastic/nodular medulloblastoma, and medulloblastoma with extensive nodularity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"31E4F8EF-4F4E-00A1-E050-BB89AD4370EE","latestVersionIndicator":"Yes","beginDate":"2016-05-02","endDate":null,"createdBy":"HAMMA","dateCreated":"2016-05-02","modifiedBy":"ONEDATA","dateModified":"2016-05-02","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"5242468","version":"1","preferredName":"Histologic Central Pathology Review Description","preferredDefinition":"Pertaining to the combined microscopic physical features of cells and their surrounding extracellular environment in tissues.:The process by which specimens are sent to a central lab for confirmatory analysis using standardized methods and result criteria in order to minimize inter-reviewer differences thereby improving the accuracy of pathology data.:A written or verbal account, representation, statement, or explanation of something.","longName":"C25526:C71684:C25365","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Histologic","conceptCode":"C25526","definition":"Pertaining to the combined microscopic physical features of cells and their surrounding extracellular environment in tissues.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Central Pathology Review","conceptCode":"C71684","definition":"The process by which specimens are sent to a central lab for confirmatory analysis using standardized methods and result criteria in order to minimize inter-reviewer differences thereby improving the accuracy of pathology data.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Description","conceptCode":"C25365","definition":"A written or verbal account, representation, statement, or explanation of something.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"31E4F8EF-4F60-00A1-E050-BB89AD4370EE","latestVersionIndicator":"Yes","beginDate":"2016-05-02","endDate":null,"createdBy":"HAMMA","dateCreated":"2016-05-02","modifiedBy":"ONEDATA","dateModified":"2016-05-02","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"COG CRF:Children's Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"31E4F8EF-4F71-00A1-E050-BB89AD4370EE","latestVersionIndicator":"Yes","beginDate":"2016-05-02","endDate":null,"createdBy":"HAMMA","dateCreated":"2016-05-02","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"5243029","version":"1","preferredName":"Medulloblastoma Histologic Classification Type","preferredDefinition":"The classifications for the molecularly distinct histological subtypes of medulloblastoma that are defined by unique molecular profiles, clinical behavior and outcomes.","longName":"5243029v1.0","context":"COG","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"100","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Not MB","valueDescription":"Not MB","ValueMeaning":{"publicId":"5243030","version":"1","preferredName":"Not MB","longName":"5243030","preferredDefinition":"Disease is not medulloblastoma.","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"31F28662-F126-1C59-E050-BB89AD43158C","latestVersionIndicator":"Yes","beginDate":"2016-05-03","endDate":null,"createdBy":"HAMMA","dateCreated":"2016-05-03","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"31F28662-F13F-1C59-E050-BB89AD43158C","beginDate":"2016-05-03","endDate":null,"createdBy":"HAMMA","dateCreated":"2016-05-03","modifiedBy":"ONEDATA","dateModified":"2016-05-03","deletedIndicator":"No"},{"value":"Indeterminate MB","valueDescription":"Indeterminate MB","ValueMeaning":{"publicId":"5243031","version":"1","preferredName":"Indeterminate MB","longName":"5243031","preferredDefinition":"Indeterminate medulloblastoma subtype.","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"31F28662-F149-1C59-E050-BB89AD43158C","latestVersionIndicator":"Yes","beginDate":"2016-05-03","endDate":null,"createdBy":"HAMMA","dateCreated":"2016-05-03","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"31F28662-F162-1C59-E050-BB89AD43158C","beginDate":"2016-05-03","endDate":null,"createdBy":"HAMMA","dateCreated":"2016-05-03","modifiedBy":"ONEDATA","dateModified":"2016-05-03","deletedIndicator":"No"},{"value":"Nodular/Desmoplastic MB & MBEN","valueDescription":"Nodular/Desmoplastic MB & MBEN","ValueMeaning":{"publicId":"5243032","version":"1","preferredName":"Nodular/Desmoplastic MB & MBEN","longName":"5243032","preferredDefinition":"Nodular/desmoplastic medulloblastoma & medulloblastoma with extensive nodularity (MBEN) subtype.","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"31F28662-F16C-1C59-E050-BB89AD43158C","latestVersionIndicator":"Yes","beginDate":"2016-05-03","endDate":null,"createdBy":"HAMMA","dateCreated":"2016-05-03","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"31F28662-F185-1C59-E050-BB89AD43158C","beginDate":"2016-05-03","endDate":null,"createdBy":"HAMMA","dateCreated":"2016-05-03","modifiedBy":"ONEDATA","dateModified":"2016-05-03","deletedIndicator":"No"},{"value":"Large cell/Anaplastic MB","valueDescription":"Large cell/Anaplastic MB","ValueMeaning":{"publicId":"5243033","version":"1","preferredName":"Large cell/Anaplastic MB","longName":"5243033","preferredDefinition":"Large cell/anaplastic (LC/A) medulloblastoma subtype.","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"31F28662-F18F-1C59-E050-BB89AD43158C","latestVersionIndicator":"Yes","beginDate":"2016-05-03","endDate":null,"createdBy":"HAMMA","dateCreated":"2016-05-03","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"31F28662-F1A8-1C59-E050-BB89AD43158C","beginDate":"2016-05-03","endDate":null,"createdBy":"HAMMA","dateCreated":"2016-05-03","modifiedBy":"ONEDATA","dateModified":"2016-05-03","deletedIndicator":"No"},{"value":"Classic MB","valueDescription":"Classic MB","ValueMeaning":{"publicId":"5243034","version":"1","preferredName":"Classic MB","longName":"5243034","preferredDefinition":"Classic medulloblastoma subtype.","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"31F28662-F1B2-1C59-E050-BB89AD43158C","latestVersionIndicator":"Yes","beginDate":"2016-05-03","endDate":null,"createdBy":"HAMMA","dateCreated":"2016-05-03","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"31F28662-F1CB-1C59-E050-BB89AD43158C","beginDate":"2016-05-03","endDate":null,"createdBy":"HAMMA","dateCreated":"2016-05-03","modifiedBy":"ONEDATA","dateModified":"2016-05-03","deletedIndicator":"No"},{"value":"Group 4","valueDescription":"Group Four","ValueMeaning":{"publicId":"7993081","version":"1","preferredName":"Group Four","longName":"7993081","preferredDefinition":"Any number of entities (members) considered as a unit.: A natural number greater than 3 and less than 5 and the quantity that it denotes: the sum of three and one.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Group","conceptCode":"C43359","definition":"Any number of entities (members) considered as a unit.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Four","conceptCode":"C66835","definition":"A natural number greater than 3 and less than 5 and the quantity that it denotes: the sum of three and one.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D43EE9C1-B5CA-19B6-E053-4EBD850AABAE","latestVersionIndicator":"Yes","beginDate":"2021-12-28","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2021-12-28","modifiedBy":"ONEDATA","dateModified":"2021-12-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D43EE9C1-B5E5-19B6-E053-4EBD850AABAE","beginDate":"2021-12-28","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2021-12-28","modifiedBy":"ONEDATA","dateModified":"2021-12-28","deletedIndicator":"No"},{"value":"SHH-activated","valueDescription":"Medulloblastoma, SHH-Activated","ValueMeaning":{"publicId":"7993080","version":"1","preferredName":"Medulloblastoma, SHH-Activated","longName":"7993080","preferredDefinition":"A molecular subtype of medulloblastoma associated with activation of the sonic hedgehog (SHH) pathway. TP53 mutations may be present or absent. Patients in this group are young children and adults. Overall survival is variable and depends on the presence or absence of metastatic disease, histology, and the age at diagnosis.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Medulloblastoma, SHH-Activated","conceptCode":"C129441","definition":"A molecular subtype of medulloblastoma associated with activation of the sonic hedgehog (SHH) pathway. TP53 mutations may be present or absent. Patients in this group are young children and adults. Overall survival is variable and depends on the presence or absence of metastatic disease, histology, and the age at diagnosis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D43EE9C1-B58C-19B6-E053-4EBD850AABAE","latestVersionIndicator":"Yes","beginDate":"2021-12-28","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2021-12-28","modifiedBy":"ONEDATA","dateModified":"2021-12-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D43EE9C1-B5A7-19B6-E053-4EBD850AABAE","beginDate":"2021-12-28","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2021-12-28","modifiedBy":"ONEDATA","dateModified":"2021-12-28","deletedIndicator":"No"},{"value":"WNT-activated","valueDescription":"WNT signaling pathway aberrant medulloblastoma","ValueMeaning":{"publicId":"4419656","version":"1","preferredName":"WNT signaling pathway aberrant medulloblastoma","longName":"4419656","preferredDefinition":"A molecular subtype of medulloblastoma associated with activation of the WNT pathway. TP53 mutations may be present or absent. WNT pathway activation in medulloblastomas is associated with good outcome.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Medulloblastoma, WNT-Activated","conceptCode":"C129440","definition":"A molecular subtype of medulloblastoma associated with activation of the WNT pathway. TP53 mutations may be present or absent. WNT pathway activation in medulloblastomas is associated with good outcome.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FF6D3778-2D69-5529-E040-BB89AD43092C","latestVersionIndicator":"Yes","beginDate":"2014-07-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-07-30","modifiedBy":"GDEEN","dateModified":"2023-07-31","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D43EE9C1-B5BD-19B6-E053-4EBD850AABAE","beginDate":"2021-12-28","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2021-12-28","modifiedBy":"ONEDATA","dateModified":"2021-12-28","deletedIndicator":"No"},{"value":"Group 3","valueDescription":"Group Three","ValueMeaning":{"publicId":"7993082","version":"1","preferredName":"Group Three","longName":"7993082","preferredDefinition":"Any number of entities (members) considered as a unit.: A natural number greater than 2 and less than 4 and the quantity that it denotes: the sum of two and one.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Group","conceptCode":"C43359","definition":"Any number of entities (members) considered as a unit.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Three","conceptCode":"C66834","definition":"A natural number greater than 2 and less than 4 and the quantity that it denotes: the sum of two and one.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D43EE9C1-B5F2-19B6-E053-4EBD850AABAE","latestVersionIndicator":"Yes","beginDate":"2021-12-28","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2021-12-28","modifiedBy":"ONEDATA","dateModified":"2021-12-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D43EE9C1-B60D-19B6-E053-4EBD850AABAE","beginDate":"2021-12-28","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2021-12-28","modifiedBy":"ONEDATA","dateModified":"2021-12-28","deletedIndicator":"No"},{"value":"Indeterminate","valueDescription":"Indeterminate","ValueMeaning":{"publicId":"2577194","version":"1","preferredName":"Indeterminate","longName":"2577194","preferredDefinition":"Cannot distinguish between two or more possible values in the current context.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Indeterminate","conceptCode":"C48658","definition":"Cannot distinguish between two or more possible values in the current context.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-FA97-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-11-14","endDate":null,"createdBy":"SBREXT","dateCreated":"2003-11-14","modifiedBy":"COOPERM","dateModified":"2008-09-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D43EE9C1-B618-19B6-E053-4EBD850AABAE","beginDate":"2021-12-28","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2021-12-28","modifiedBy":"ONEDATA","dateModified":"2021-12-28","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2435013","version":"1","preferredName":"Biological Process","preferredDefinition":"An activity that occurs between organisms or that occurs within an organism and involves the function, or modification of function by external factors, of biologic molecules, biologic complexes, subcellular components, cells, tissues, organs, or organ systems.","longName":"C17828 ","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741AABF-C6A4-2728-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2234813","version":"1","preferredName":"Type","preferredDefinition":"Type; a subdivision of a particular kind of thing.","longName":"C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"F970CDF6-F90E-21D3-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-14","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-06-14","modifiedBy":"SBR","dateModified":"2005-09-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"COG CRF:Children's Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"31F28662-F110-1C59-E050-BB89AD43158C","latestVersionIndicator":"Yes","beginDate":"2016-05-03","endDate":null,"createdBy":"HAMMA","dateCreated":"2016-05-03","modifiedBy":"SPRINGERL","dateModified":"2021-12-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2961451","version":"1","longName":"Children's Oncology Group (COG)","context":"COG","ClassificationSchemeItems":[{"publicId":"2961452","version":"1","longName":"Statistics and Data Center","context":"COG"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Histology type:","type":"Preferred Question Text","description":"Histology type:","url":null,"context":"COG"},{"name":"COG CRF Text 001","type":"Alternate Question Text","description":"Final Medulloblastoma Subgroup Determination:","url":null,"context":"COG"},{"name":"COG CRF Text 1","type":"Alternate Question Text","description":"Medulloblastoma Group:","url":null,"context":"COG"}],"origin":"COG CRF:Children's Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"31F56237-717E-FB12-E050-BB89AD43450B","latestVersionIndicator":"Yes","beginDate":"2016-05-03","endDate":null,"createdBy":"HAMMA","dateCreated":"2016-05-03","modifiedBy":"SPRINGERL","dateModified":"2022-01-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}